Latest Atheroma Stories
New procedure rooms offer faster and more accurate diagnosis and treatment. LANGHORNE, Pa., Feb. 17 /PRNewswire/ -- St. Mary Medical Center today announces the completion of its state-of-the-art procedure rooms in a completely new cardiovascular catheterization suite.
BOSTON, Jan. 26 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced today that the United States Patent and Trademark Office issued U.S. Patent No.
Current research suggests that inflammation increases the risk of plaque rupture in atherosclerosis.
ROCKVILLE, Md., Dec.
SAN FRANCISCO, Sept. 24 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc.
SAN FRANCISCO, Sept. 15 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc.
SAN DIEGO, Calif., Sept.
Mission Internal Medical Group's Dr. David Kawanishi is happy about his recent decision to include HeartSmartIMTplus in his cardiology practice.
BG Medicine, a life sciences company focused on the discovery, development and commercialization of novel diagnostics, today announced the publication* of the biomarker discovery study yielding its novel diagnostic candidate for the detection of ruptured plaque, the underlying condition for the majority of heart attacks and stroke.
SAN FRANCISCO, July 10 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it has completed the last patient visit in its carotid endarterectomy (CEA) study.
- A political dynamiter.